Live Breaking News & Updates on Diamedica therapeutics inc
Stay updated with breaking news from Diamedica therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Monday, August 14th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter. DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) last announced its quarterly earnings data on Monday, May 15th. The […]
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 for the treatment of acute ischemic stroke, announced today that its second...
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […]
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders, today announced the company will be attending the 2023 AAN...
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) major shareholder Koch Thomas Von bought 1,470,588 shares of DiaMedica Therapeutics stock in a transaction on Friday, June 23rd. The shares were acquired at an average price of $3.40 per share, for a total transaction of $4,999,999.20. Following the completion of the acquisition, the insider now owns 4,326,435 […]
DiaMedica Therapeutics Inc. (DMAC) Announces 11.01M Share Offering by Selling Stockholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) insider David J. Wambeke purchased 38,364 shares of the business’s stock in a transaction on Friday, June 23rd. The shares were bought at an average cost of $3.91 per share, for a total transaction of $150,003.24. Following the purchase, the insider now owns 507,114 shares of the company’s […]